quinoxalines has been researched along with Memory Disorders in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bacher, I; George, TP; Rabin, RA; Wass, CE; Wing, VC | 1 |
| Barik, J; Bethus, I; Chafai, M; Kootar, S; Lanté, F; Marie, H; Mouska, X; Pereira, AR; Raymond, EF | 1 |
| Basu, AC; Benneyworth, MA; Bergeron, R; Coyle, JT; Ehmsen, JT; Froimowitz, MP; Han, L; Jiang, ZI; Lange, N; Ma, CL; Mustafa, AK; Snyder, SH; Tsai, GE | 1 |
| Frey, J; Gur, R; Jepson, C; Lerman, C; Loughead, J; Patterson, F; Perkins, K; Siegel, S; Strasser, AA | 1 |
| Hrupka, B; Pemberton, DJ; Pollard, M; Shaban, H; Steckler, T; Varin, C | 1 |
| Dong, J; Liu, C; Liu, D; Liu, XB; Luo, J; Min, S; Wei, K | 1 |
| Harrison-Woolrych, M; Tan, M | 1 |
| Birthelmer, A; Cassel, JC; Jackisch, R; Stemmelin, J | 1 |
| Birthelmer, A; Cassel, JC; Jackisch, R; Lazaris, A; Schweizer, T | 1 |
| Chung, EH; Egashira, N; Egawa, T; Fujiwara, M; Hatip-Al-Khatib, I; Irie, K; Iwasaki, K; Mishima, K | 1 |
| Edwards, TM; Lindley, N | 1 |
| Gould, TJ; Gulick, D | 1 |
| Bianchin, M; Bueno e Silva, M; Da Silva, RC; Izquierdo, I; Medina, JH; Paczko, N; Ruschel, AC; Walz, R; Zanatta, MS | 1 |
| Baubichon, D; Burckhart, MF; Carpentier, P; Filliat, P; Foquin, A; Lallement, G; Masqueliez, C; Pernot-Marino, I; Perrichon, C | 1 |
1 trial(s) available for quinoxalines and Memory Disorders
| Article | Year |
|---|---|
Working memory deficits predict short-term smoking resumption following brief abstinence.
Topics: Adolescent; Adult; Attention; Benzazepines; Female; Humans; Male; Memory Disorders; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Nicotinic Agonists; Predictive Value of Tests; Psychomotor Performance; Quinoxalines; Recurrence; Regression Analysis; Smoking; Smoking Cessation; Socioeconomic Factors; Treatment Outcome; Varenicline; Young Adult | 2010 |
13 other study(ies) available for quinoxalines and Memory Disorders
| Article | Year |
|---|---|
Varenicline modulates spatial working memory deficits in smokers with schizophrenia.
Topics: Analysis of Variance; Benzazepines; Dose-Response Relationship, Drug; Female; Humans; Male; Memory Disorders; Neuropsychological Tests; Nicotinic Agonists; Psychiatric Status Rating Scales; Quinoxalines; Schizophrenia; Schizophrenic Psychology; Smoking; Varenicline | 2013 |
Subchronic glucocorticoid receptor inhibition rescues early episodic memory and synaptic plasticity deficits in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Dexamethasone; Disease Models, Animal; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Glucocorticoids; Hippocampus; Hormone Antagonists; Humans; Memory Disorders; Memory, Episodic; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mifepristone; Mutation; Neuronal Plasticity; Quinoxalines; Receptors, Glucocorticoid; Recognition, Psychology; Valine | 2015 |
Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior.
Topics: Acoustic Stimulation; Anesthetics, Local; Animals; Behavior, Animal; Benzylamines; Biotin; Chromatography, High Pressure Liquid; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Glutamic Acid; Hippocampus; In Vitro Techniques; Inhibition, Psychological; Lidocaine; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Neurons; Patch-Clamp Techniques; Phosphinic Acids; Psychomotor Performance; Quinoxalines; Racemases and Epimerases; Rotarod Performance Test; Space Perception | 2009 |
Synaptic transmission changes in fear memory circuits underlie key features of an animal model of schizophrenia.
Topics: Action Potentials; Amygdala; Animals; Area Under Curve; Biophysics; Disease Models, Animal; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Extinction, Psychological; Fear; Glutamate Decarboxylase; Hippocampus; In Vitro Techniques; Male; Memory Disorders; Neurons; Parvalbumins; Patch-Clamp Techniques; Phencyclidine; Quinoxalines; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Schizophrenia; Synaptic Transmission; Time Factors | 2012 |
[MK-801 or DNQX reduces electroconvulsive shock-induced impairment of learning-memory and hyperphosphorylation of Tau in rats].
Topics: Animals; Disease Models, Animal; Dizocilpine Maleate; Electroshock; Excitatory Amino Acid Antagonists; Glutamic Acid; Hippocampus; Learning; Memory; Memory Disorders; Phosphorylation; Quinoxalines; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; tau Proteins | 2012 |
Memory impairment associated with varenicline: a case series from the New Zealand Intensive Medicines Monitoring Programme.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Benzazepines; Female; Humans; Male; Memory Disorders; Middle Aged; New Zealand; Nicotinic Agonists; Quinoxalines; Varenicline | 2013 |
Presynaptic modulation of acetylcholine, noradrenaline, and serotonin release in the hippocampus of aged rats with various levels of memory impairments.
Topics: Acetylcholine; Acetylcholinesterase; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Aging; Analysis of Variance; Animals; Behavior, Animal; Brimonidine Tartrate; Choline O-Acetyltransferase; Female; Hippocampus; Idazoxan; In Vitro Techniques; Maze Learning; Memory Disorders; Methiothepin; Muscarinic Agonists; Norepinephrine; Oxotremorine; Presynaptic Terminals; Pyridines; Pyrroles; Quinoxalines; Rats; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming; Tritium | 2003 |
Presynaptic regulation of neurotransmitter release in the cortex of aged rats with differential memory impairments.
Topics: Acetylcholine; Acetylcholinesterase; Adrenergic alpha-Agonists; Aging; Animals; Brimonidine Tartrate; Cerebral Cortex; Choline; Choline O-Acetyltransferase; Chromatography, High Pressure Liquid; Electric Stimulation; Female; Maze Learning; Memory Disorders; Muscarinic Agonists; Neurotransmitter Agents; Norepinephrine; Oxotremorine; Pyridines; Pyrroles; Quinoxalines; Rats; Rats, Long-Evans; Receptors, Presynaptic; Serotonin; Serotonin Receptor Agonists | 2003 |
Non-NMDA mechanism in the inhibition of cellular apoptosis and memory impairment induced by repeated ischemia in rats.
Topics: Animals; Apoptosis; Brain Ischemia; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Hippocampus; Male; Maze Learning; Memory Disorders; Nerve Degeneration; Neurons; Neuroprotective Agents; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Recovery of Function; Reperfusion Injury | 2004 |
Phosphodiesterase type 5 inhibition coupled to strong reinforcement results in two periods of transient retention loss in the young chick.
Topics: Analysis of Variance; Animals; Animals, Newborn; Avoidance Learning; Behavior, Animal; Chickens; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Discrimination, Psychological; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Memory Disorders; Phosphodiesterase 5 Inhibitors; Purinones; Quinoxalines; Reinforcement, Psychology; Retention, Psychology; Time Factors | 2007 |
Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice.
Topics: Acetylcholine; Alcoholism; Animals; Benzazepines; Central Nervous System Depressants; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; Freezing Reaction, Cataleptic; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Quinoxalines; Smoking Cessation; Varenicline | 2008 |
Memory expression is blocked by the infusion of CNQX into the hippocampus and/or the amygdala up to 20 days after training.
Topics: Amygdala; Animals; Avoidance Learning; Habituation, Psychophysiologic; Hippocampus; Male; Memory Disorders; Quinoxalines; Rats; Retention, Psychology | 1993 |
Memory impairment after soman intoxication in rat: correlation with central neuropathology. Improvement with anticholinergic and antiglutamatergic therapeutics.
Topics: Animals; Antidotes; Atropine; Behavior, Animal; Cholinergic Antagonists; Convulsants; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Hippocampus; Male; Maze Learning; Memory Disorders; Neuroprotective Agents; Phencyclidine; Quinoxalines; Rats; Rats, Wistar; Soman; Spatial Behavior; Survival Rate; Time Factors | 1999 |